IR

IR News

• 2024.09.17
  Transcript for Financial Result Presentation for the Third Quarter ending July 2024（12MB）
• 2024.09.12
  Notice Concerning Revisions to Full-Year Financial Results Forecasts（303KB）
• 2024.09.12
  Notice Regarding Acquisition of Medibase as a Wholly Owned Subsidiary Through Share Purchase（210KB）
• 2024.09.12
  CellSource Advances Processing Technology for Contract Processing Services of Adipose-Derived Stem Cells（176KB）
• 2024.09.12
  Earnings Presentation Q3 FY10/2024（1MB）
• 2024.09.12
  [Summary]Non-consolidated Financial Results for the Nine Months Ended July 31, 2024 (Under Japanese GAAP)（236KB）
• 2024.07.31
  CellSource’s Egg Freezing Anshin Bank Service Adopted for FamilyMart’s Employee Benefit Program（221KB）
• 2024.07.16
  CellSource Awarded Contract to Operate Online Information Sessions for Tokyo Metropolitan Government’s Egg Freezing Program（277KB）
• 2024.07.03
  CellSource’s Egg Freezing Anshin Bank Service Adopted for Unicham’s Employee Benefit Program（364KB）
• 2024.06.18
  Transcript for Financial Result Presentation for the Second Quarter ending April 2024（10MB）
• 2024.06.14
  [Delayed] Earnings Presentation Q2 FY10/2024（726KB）
• 2024.06.13
  [Summary]Non-consolidated Financial Results for the Six Months Ended April 30, 2024 (Under Japanese GAAP)（280KB）
• 2024.04.15
  Anicom Animal Hospital Group Begins Offering cPGF ™: Canine Platelet-derived Growth Factor Therapy（261KB）
• 2024.04.09
  CellSource’s Egg Freezing Anshin Bank Service Adopted for CREEK & RIVER’s Employee Benefit Program（325KB）
• 2024.03.15
  Earnings Presentation Q1 FY/2024（1MB）
• 2024.03.13
  Transcript for Financial Result Presentation for the First Quarter ending January 2024（233KB）
• 2024.03.11
  CellSource’s Egg Freezing Anshin Bank Service Adopted as LIFE CREATE’s Employee Benefit Program（268KB）
• 2024.03.11
  Notice of Grant of Stock Transfer Options from Major Shareholders to the Representative Director and CEO（156KB）
• 2024.03.11
  CellSource Advances Processing Technology for Contract Processing Services of Adipose-Derived Stem Cells and Blood-Derived Products（217KB）
• 2024.03.11
  Non-consolidated Financial Results for the Three Months Ended January 31, 2024 (Under Japanese GAAP)（121KB）
• 2024.03.08
  CellSource Provides Egg Freezing Anshin Bank Service to ITOCHU Corporation, the First Time the Service Has Been Included in a Welfare Benefit Program（285KB）
• 2024.03.06
  CellSource and mederi Enter into Business Alliance Agreement to Jointly Promote Egg Freezing and Storage Service（318KB）
• 2024.02.22
  CellSource Launches Egg Freezing Anshin Bank, an Egg Freezing and Storage Contract Service, Today（1MB）
• 2024.01.25
  Notice of Personnel Changes of Directors and Executive Officers（124KB）
• 2024.01.15
  Financial Result Presentation for the Fiscal Year Ended October 31, 2023（4MB）
• 2024.01.15
  Transcript for Financial Result Presentation for the Fiscal Year Ended October 31, 2023（217KB）
• 2023.12.16
  Notice of Convocation Annual General Meeting 2024（256KB）
• 2023.12.15
  Non-consolidated Financial Results for the Fiscal Year Ended October 31, 2023 (Under Japanese GAAP)（391KB）
• 2023.09.13
  Non-consolidated Financial Results for the Nine Months Ended July 31, 2023 (Under Japanese GAAP)（259KB）
• 2023.06.14
  Non-consolidated Financial Results for the Six Months Ended April 30, 2023(Under Japanese GAAP)（278KB）
• 2023.03.14
  Non-consolidated Financial Results for the Three Months Ended January 31, 2023 (Under Japanese GAAP)（212KB）
• 2022.12.27
  Notice of Convocation Annual General Meeting 2023（315KB）
• 2022.12.14
  Non-consolidated Financial Results for the Fiscal Year Ended October 31, 2022(Under Japanese GAAP)（355KB）